Conclusions
macrosomia, weight gain, GDM
GDM, NEONATAL HYPOGLYCAEMIA
In summary, FGM application resulted in significantly better improvement in glycaemic control in the 3rd and 4th week of the study. FGM led to higher EAT score, that might indicate better diet modifications after GDM diagnosis; however, it had no impact on lifestyle interventions including gestational weight gain, qualification to insulin therapy or dosage of insulin. FGM significantly decreased incidence of fetal macrosomia, but had no significant impact on birthweight percentile or neonatal hypoglycaemia incidence. Therefore, further studies are needed to analyse the impact of FGM on improving perinatal outcomes in GDM-complicated pregnancies.
